These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32344183)

  • 21. Discovery of cinnoline derivatives as potent PI3K inhibitors with antiproliferative activity.
    Tian C; Yang C; Wu T; Lu M; Chen Y; Yang Y; Liu X; Ling Y; Deng M; Jia Y; Zhou Y
    Bioorg Med Chem Lett; 2021 Sep; 48():128271. PubMed ID: 34284105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity.
    Liao W; Wang Z; Han Y; Qi Y; Liu J; Xie J; Tian Y; Lei Q; Chen R; Sun M; Tang L; Gong G; Zhao Y
    Eur J Med Chem; 2020 Jul; 197():112309. PubMed ID: 32375077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and synthesis of 2-amino-1-methyl-1H-imidazol-4(5H)-ones as GPCR ligands; an approach to develop breast cancer drugs via GPCR associated PAR1 and PI3Kinase inhibition mechanism.
    Ashok SR; Shivananda MK; Manikandan A; Chandrasekaran R
    Bioorg Chem; 2019 May; 86():641-651. PubMed ID: 30822721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives.
    Ouyang G; Tong R; Li J; Bai L; Ouyang L; Duan X; Li F; He P; Shi J; He Y
    Molecules; 2016 Apr; 21(4):516. PubMed ID: 27104509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors.
    Wu TT; Guo QQ; Chen ZL; Wang LL; Du Y; Chen R; Mao YH; Yang SG; Huang J; Wang JT; Wang L; Tang L; Zhang JQ
    Eur J Med Chem; 2020 Oct; 204():112637. PubMed ID: 32717477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss.
    Xu S; Luo L; Sun X; Yang Y; Guo Q; Jiang Z; Wu Y
    Bioorg Med Chem; 2023 Jan; 78():117133. PubMed ID: 36599263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
    Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
    Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.
    Dong FD; Liu DD; Deng CL; Qin XC; Chen K; Wang J; Song HR; Ding HW
    Bioorg Med Chem; 2018 Aug; 26(14):3982-3991. PubMed ID: 29937355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Novel Thiazolo[5,4-
    Xia L; Zhang Y; Zhang J; Lin S; Zhang K; Tian H; Dong Y; Xu H
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro cytotoxic evaluation of new 1H-benzo[d]imidazole derivatives of dehydroabietic acid.
    Gu W; Miao TT; Hua DW; Jin XY; Tao XB; Huang CB; Wang SF
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1296-1300. PubMed ID: 28169166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors.
    Wang Y; Liu Y; Ge T; Tang J; Wang S; Gao Z; Chen J; Xu J; Gong P; Zhao Y; Liu J; Hou Y
    Bioorg Chem; 2023 Jan; 130():106211. PubMed ID: 36343598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological evaluation of new thieno[2,3-
    Elmenier FM; Lasheen DS; Abouzid KAM
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):315-332. PubMed ID: 34955086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis and Preliminary Biological Evaluation of Benzylsulfone Coumarin Derivatives as Anti-Cancer Agents.
    Wang T; Peng T; Wen X; Wang G; Sun Y; Liu S; Zhang S; Wang L
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31703373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, antitumor evaluation and computational study of thiazolidinone derivatives of dehydroabietic acid-based B ring-fused-thiazole.
    Chen NY; Li CP; Huang HF
    Mol Divers; 2024 Apr; 28(2):875-888. PubMed ID: 36862356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, biological evaluation, and in silico studies of 2-aminobenzothiazole derivatives as potent PI3Kα inhibitors.
    Haider K; Ahmad K; Najmi AK; Das S; Joseph A; Shahar Yar M
    Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200146. PubMed ID: 35665957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L; Wu TT; Wang Z; Xue JY; Xu YG
    Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
    Liang Y; Zhou Y; Deng S; Chen T
    ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
    Paul K; Bindal S; Luxami V
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of novel 4-alkynyl-quinoline derivatives as PI3K/mTOR dual inhibitors.
    Lv X; Ying H; Ma X; Qiu N; Wu P; Yang B; Hu Y
    Eur J Med Chem; 2015 Jun; 99():36-50. PubMed ID: 26046312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
    Huang XC; Jin L; Wang M; Liang D; Chen ZF; Zhang Y; Pan YM; Wang HS
    Eur J Med Chem; 2015 Jan; 89():370-85. PubMed ID: 25462253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.